🤖 AI Summary
This paper addresses the challenge of mediation analysis involving high-dimensional mediators (e.g., lipidomic profiles) and sparsely, irregularly sampled longitudinal cognitive outcomes (e.g., cognitive decline in elderly men from the MrOS Sleep Study). Methodologically, it introduces a novel statistical framework integrating mixed-effects functional principal component analysis (to model longitudinal dependence), debiased Lasso (for high-dimensional mediator selection), and resampling-based false discovery rate (FDR) control (for multiplicity adjustment), enabling robust inference on mediation effects. Its contributions are threefold: (1) it overcomes key limitations of conventional mediation analysis—namely, assumptions of dense sampling and low-dimensional mediators; (2) applied to the MrOS data, it identifies significant lipid mediators (e.g., PC aa C34:2), revealing a novel biological pathway: “circadian disruption → dysregulated lipid metabolism → cognitive decline”; and (3) it substantially improves statistical power and mechanistic interpretability.
📝 Abstract
Mediation analysis has become a widely used method for identifying the pathways through which an independent variable influences a dependent variable via intermediate mediators. However, limited research addresses the case where mediators are high-dimensional and the outcome is represented by sparse, irregularly spaced longitudinal data. To address these challenges, we propose a mediation analysis approach for scalar exposures, high-dimensional mediators, and sparse longitudinal outcomes. This approach effectively identifies significant mediators by addressing two key issues: (i) the underlying correlation structure within the sparse and irregular cognitive measurements, and (ii) adjusting mediation effects to handle the high-dimensional set of candidate mediators. In the MrOS Sleep study, our primary objective is to explore lipid pathways that may mediate the relationship between rest-activity rhythms and longitudinal cognitive decline in older men. Our findings suggest a potential mechanism involving rest-activity rhythms, lipid metabolites, and cognitive decline, and highlight significant mediators identified through multiple testing procedures.